Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_assertion type Assertion NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_head.
- NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_assertion description "[The present study analyzed the expression of the following 13 TFs: AML1, CEBPA, E2A, ETS1, GATA1, GATA2, GATA3, IKAROS, IRF1, PAX5, PU1, TBET and TCF1 in 7 malignant NK-cell lines together with 5 malignant NKT-cell lines, 5 T-cell acute lymphoblastic leukemia (ALL) cell lines including 3 gamma/delta T-cell receptor (TCR) type and 2 alpha/beta TCR type, and 3 B-cell precursor (BCP) leukemia cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_provenance.
- NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_assertion evidence source_evidence_literature NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_provenance.
- NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_assertion SIO_000772 15369140 NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_provenance.
- NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_assertion wasDerivedFrom befree-20140225 NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_provenance.
- NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_assertion wasGeneratedBy ECO_0000203 NP932631.RAyYZ667AKGLf7KV_0jSzS6PNXydSR9qg_UJiaFXyZRHs130_provenance.